RILSERA
Live / Applied — First extension granted (statement of use) (as of 04 Nov 2025)
What this means for you
Not registered yet, but its 19 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98911608
- Mark type
- Stylized text
- Filed
- 19 Dec 2024
- Published for opposition
- 22 Apr 2025
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of immunological, inflammatory, respiratory, immune-mediated, and autoimmune diseases and disorders
Owner
- Principia Biopharma Inc., Morristown, NJ, US
- Principia Biopharma Inc., Bridgewater, NJ, US
Prosecution history
- 05 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2025 — SOU EXTENSION 1 GRANTED
- 04 Nov 2025 — SOU EXTENSION 1 FILED
- 04 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Apr 2025 — PUBLISHED FOR OPPOSITION
- 16 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Mar 2025 — ASSIGNED TO EXAMINER
- 23 Jan 2025 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED